Check-Cap Ltd. (CHEK)

USD 0.6

(-0.84%)

Market Cap (In USD)

3.51 Million

Revenue (In USD)

-

Net Income (In USD)

-17.56 Million

Avg. Volume

10.02 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.6-3.45
PE
-
EPS
-
Beta Value
0.179
ISIN
IL0011336851
CUSIP
M2361E203
CIK
1610590
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Saar Levi
Employee Count
-
Website
https://www.check-cap.com
Ipo Date
2015-03-04
Details
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.